20
Participants
Start Date
January 31, 2012
Primary Completion Date
December 31, 2012
Study Completion Date
April 30, 2013
Chloroquine prophylaxis
Standard prophylactic regime: a loading dose of 300 mg on day 14 and day 17 and then 300 mg once a week, starting on day 21, for a total duration of 13 weeks. On day 0, day 3, day 7 and day 10, this group will receive a placebo.
Mefloquine prophylaxis
Mefloquine prophylaxis, starting with a loading regime of split doses during the first three weeks: 125 mg on day 0, day 3, day 7, day 10, day 14 and day 17 and 250 mg once a week from day 21 onwards for a total duration of 13 weeks.
Immunization
Group 1 and 2 will receive three immunizations with Plasmodium falciparum infected mosquito-bites. Group 3 will receive an equal number of uninfected mosquito-bites.
Controlled Human Malaria Infection
Exposure to the bites of 5 Plasmodium falciparum infected mosquitoes.
Malarone
When thick smear positive, of ar day 21 after challenge, all volunteers will be treated with malarone.
Leiden University Medical Centre, Leiden
ZonMw: The Netherlands Organisation for Health Research and Development
OTHER
Radboud University Medical Center
OTHER